Search Within

Mark Lee

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (8)
  2. Research Letter (1)
Groups
  1. Human Oncology and Pathogenesis Program (9)
  2. Sloan Kettering Institute Postdocs (9)
  3. Surgery (9)
  4. GME, Surgery (8)
  5. GSK Faculty (8)
  6. Graduate Medical Education (8)

More Groups

People
  1. Luc Morris (9)
  2. Cristina Valero Mayor (8)
  3. Timothy Chan (7)
  4. Abraham Hakimi (6)
  5. Douglas Hoen (5)
  6. Nadeem Riaz (5)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (1)
Publications
  1. Molecular Cancer Research (2)
  2. Clinical Cancer Research (1)
  3. JAMA Oncology (1)
  4. Journal of Clinical Investigation (1)
  5. Nature Biotechnology (1)
  6. Nature Communications (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Association for Cancer Research (3)
  3. American Medical Association (1)
  4. American Society for Clinical Investigation (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
    Journal Article

    Yoo, S. K.; Fitzgerald, C. W.; Cho, B. A.; Fitzgerald, B. G.; Han, C.; Koh, E. S.; Pandey, A.; Sfreddo, H.; Crowley, F.; Korostin, M. R.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
    Journal Article

    Valero, C.; Golkaram, M.; Vos, J. L.; Xu, B.; Fitzgerald, C.; Lee, M.; Kaplan, S.; Han, C. Y.; Pei, X.; Sarkar, R.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy
    Journal Article

    Lee, M.; Untch, B. R.; Xu, B.; Ghossein, R.; Han, C.; Kuo, F.; Valero, C.; Nadeem, Z.; Patel, N.; Makarov, V.; more...
    Molecular Cancer Research (2022)

    Fulltext@MSK | Save
  • High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab
    Journal Article

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Valero, C.; Vuong, L.; Lee, M.; Weiss, K.; Hoen, D.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Response rates to anti-PD-1 immunotherapy in microsatellite-stable solid tumors with 10 or more mutations per megabase
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Zehir, A.; Berger, M. F.; Seshan, V. E.; Chan, T. A.; Morris, L. G. T.
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • The immune microenvironment and noantigen landscape of aggressive salivary gland carcinomas differ by subtype
    Journal Article

    Linxweiler, M.; Kuo, F.; Katabi, N.; Lee, M.; Nadeem, Z.; Dalin, M. G.; Makarov, V.; Chowell, D.; Dogan, S.; Ganly, I.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save